Many people have asked about the investment logic of a certain biotechnology stock. To be honest, I just want to test the waters with this target. After looking through its financial statements, the data performance is quite good, and it does show signs of being pushed down in price. But look at how much I've actually invested? Doubling it would only yield a 0.6% profit, and halving it would only result in a 0.3% loss—this is not a serious Heavy Position, at best it’s just a small observation Position for fun. If I were to increase it to more than 3% of my total Position, that would indicate that I am really optimistic about it, and then we can dive deeper into discussing this stock. Right now? It’s purely in the trial-and-error stage.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Many people have asked about the investment logic of a certain biotechnology stock. To be honest, I just want to test the waters with this target. After looking through its financial statements, the data performance is quite good, and it does show signs of being pushed down in price. But look at how much I've actually invested? Doubling it would only yield a 0.6% profit, and halving it would only result in a 0.3% loss—this is not a serious Heavy Position, at best it’s just a small observation Position for fun. If I were to increase it to more than 3% of my total Position, that would indicate that I am really optimistic about it, and then we can dive deeper into discussing this stock. Right now? It’s purely in the trial-and-error stage.